Tadeus Reichstein

Tadeus Reichstein was a Polish-born Swiss chemist and Nobel laureate whose pioneering work in organic chemistry had a profound impact on medicine and biochemistry. He is best known for his role in the first synthesis of vitamin C and, most significantly, for his isolation and elucidation of the hormones of the adrenal cortex, which led to the development of cortisone as a therapeutic agent. His distinguished career was spent primarily at the ETH Zurich and the University of Basel, where his meticulous research bridged chemistry and physiology.

Early life and education

Born in Włocławek in the Russian Empire, Reichstein moved with his family to Kiev and later to Berlin during his youth. He began his higher education studying chemical engineering at the ETH Zurich in Switzerland, where he developed a deep interest in organic chemistry. Under the mentorship of prominent chemists like Hermann Staudinger, he completed his doctorate in 1922, focusing on the aromatic compounds found in coffee. This early work established his reputation for precise analytical techniques and a lifelong fascination with natural products.

Career and research

After his doctorate, Reichstein remained at ETH Zurich, rising through the academic ranks to become a professor. His early independent research continued on flavors and scents, but a pivotal shift occurred in the early 1930s. In 1933, building on the work of Sir Norman Haworth, Reichstein and his colleagues achieved the first practical chemical synthesis of ascorbic acid, known as vitamin C. This so-called "Reichstein process" was industrially viable and revolutionized the production of the vitamin. He then turned his attention to the complex steroids of the adrenal gland. In a monumental series of experiments, his group isolated over 29 different substances from the adrenal cortex, including the critically important compound cortisone.

Nobel Prize and later work

In 1950, Reichstein was awarded the Nobel Prize in Physiology or Medicine jointly with Philip S. Hench and Edward C. Kendall "for their discoveries relating to the hormones of the adrenal cortex, their structure and biological effects." His chemical isolation and identification work was the foundation that allowed Kendall and Hench to develop cortisone as a treatment for rheumatoid arthritis. Following the prize, Reichstein continued his prolific research at the University of Basel, where he had become Director of the Pharmaceutical Institute in 1946. His later investigations expanded into the chemistry of cardiac glycosides from plants like Digitalis and the structure of various alkaloids.

Personal life and legacy

Reichstein became a naturalized citizen of Switzerland in 1914. He was known as a modest, dedicated, and exceptionally meticulous scientist who preferred the laboratory to the limelight. An avid botanist, he maintained a large herbarium and had a deep love for the flora of the Alps. His legacy endures through the widespread therapeutic use of corticosteroids for inflammatory and autoimmune diseases, which originated from his chemical isolations. The Reichstein process for vitamin C synthesis remained the dominant industrial method for decades, and his rigorous approach set a standard in natural products chemistry.

Awards and honors

Beyond the Nobel Prize, Reichstein received numerous prestigious recognitions. These included the Marcel Benoist Prize in 1947, often called the "Swiss Nobel Prize." In 1952, he was elected a Foreign Member of the Royal Society (ForMemRS). The Royal Society later awarded him its highest honor, the Copley Medal, in 1968. He held honorary doctorates from many institutions, including the University of Paris, the University of Geneva, and the University of Zurich. Several academic awards and lectureships bear his name, commemorating his foundational contributions to science.

Category:Swiss chemists Category:Nobel laureates in Physiology or Medicine Category:ETH Zurich alumni Category:University of Basel faculty